Table 1.
Baseline Clinical Characteristics for OAT-EP and other OAT patients
| OAT-EP PCI Group (N=149) | OAT-EP MED Group (N=151) | OAT-EP Both Groups (N=300) | Other OAT Patients (N=1901) | |
|---|---|---|---|---|
| Age,years,mean±SD | 57.2±10.5 | 57.6±10.5 | 57.4±10.5 | 58.8±11.0 |
| Male,n(%) | 111(74.5) | 127(84.1) | 238(79.3) | 1479(77.8) |
| Race,n(%) | ||||
| White | 115(77.2) | 117(77.5) | 232(77.3) | 1531(80.5) |
| Black | 3(2.0) | 4(2.6) | 7(2.3) | 62(3.3) |
| Hispanic | 26(17.4) | 21(13.9) | 47(15.7) | 230(12.1) |
| Other | 5(3.4) | 9(6.0) | 14(4.7) | 78(4.1) |
| No.(%) with history of: | ||||
| Angina | 28(18.8) | 30(19.9) | 58(19.3) | 437(23.0) |
| Prior MI | 10(6.7) | 10(6.6) | 20(6.7) | 227(11.9) |
| Cerebrovascular disease | 4(2.7) | 6(4.0) | 10(3.3) | 72(3.8) |
| Peripheral vascular disease | 5(3.4) | 6(4.0) | 11(3.7) | 72(3.8) |
| Congestive heart failure | 5(3.4) | 3(2.0) | 8(2.7) | 44(2.3) |
| Prior PCI | 5(3.4) | 10(6.6) | 15(5.0) | 90(4.7) |
| Diabetes | 22(14.8) | 40(26.5) | 62(20.7) | 392(20.6) |
| Hypertension | 81(54.4) | 94(62.3) | 175(58.3) | 896(47.1) |
| Current smoker,n(%) | 55(36.9) | 64(42.4) | 119(39.7) | 740(38.9) |
| NYHA class at randomization,n(%) | ||||
| NYHA class I | 126(84.6) | 122(80.8) | 248(82.7) | 1582(83.4) |
| NYHA class II | 23(15.4) | 29(19.2) | 52(17.3) | 315(16.6) |
| NYHA class III or IV | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) |
| Glomerular filtration rate,ml/min,mean±SD | 83.5±23.6 | 83.5±23.5 | 83.5±23.5 | 80.2±21.2 |